EUVIMEDEUVIMED entdecken
Open Access

Status of universal drug-susceptibility testing among sputum smear-positive tuberculosis patients diagnosed at a tertiary care centre

Pal Debolina, Chinnakali Palanivel, Rajaram Manju, Rehman Tanveer

Indian Journal of Medical Research · 2023

DOI: 10.4103/ijmr.ijmr_4148_20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Medical Research, 2023. Verfasst von Pal Debolina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: This study was aimed at estimating the proportion among sputum smear-positive tuberculosis (TB) patients diagnosed at a tertiary care centre in India, who did not undergo universal drug-susceptibility testing (UDST), assessing the sociodemographic and morbidity-related factors associated with it, ascertaining the reasons for not getting tested and estimating the proportion with any drug resistance (DR).

Methods

TB Notification Register and TB Laboratory Register, maintained in Designated Microscopy Centre and Intermediate Research Laboratory, respectively were used to obtain the patient details and information regarding UDST and DR-TB status. Under UDST, the TB patients had undergone rapid molecular tests to check for any DR. TB patients who dropped out of this strategy (those who did not submit a sputum sample for DR testing even after being instructed) were telephonically contacted and asked regarding reasons for not getting themselves tested.

Results

Of the 215 patients, 74 [34.4%, 95% confidence interval (CI): 28.1-41.2] did not undergo UDST. Of these 74 participants, 60 per cent reported the reason that they were not informed regarding the drug-susceptibility test. Among the 141 patients who underwent UDST, six (4.3%, 95%. CI: 1.58-9.03) had DR. Non-UDST patients were significantly more in percentage among TB patients who were aged 60 years. Interpretation & conclusions: The present findings point towards a need to sensitize healthcare workers and TB patients to improve UDST.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisTuberculosis, Multidrug-ResistantHumansSputumTertiary Care CentersPrevalenceAntitubercular Agents

Stichwörter der Autor:innen

Cross-sectional studiesdrug resistancemedical recordsoperational researchtuberculosisuniversal drug-susceptibility testing

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
  • Department of Preventive & Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
  • Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Zitieren

APA

Debolina, P., Palanivel, C., Manju, R., & Tanveer, R. (2023). Status of universal drug-susceptibility testing among sputum smear-positive tuberculosis patients diagnosed at a tertiary care centre. Indian Journal of Medical Research. https://doi.org/10.4103/ijmr.ijmr_4148_20

Vancouver

Debolina P, Palanivel C, Manju R, Tanveer R. Status of universal drug-susceptibility testing among sputum smear-positive tuberculosis patients diagnosed at a tertiary care centre. Indian Journal of Medical Research. 2023. doi:10.4103/ijmr.ijmr_4148_20

BibTeX
@article{Debolina2023,
  author = {Debolina, Pal and Palanivel, Chinnakali and Manju, Rajaram and Tanveer, Rehman},
  title = {Status of universal drug-susceptibility testing among sputum smear-positive tuberculosis patients diagnosed at a tertiary care centre},
  journal = {Indian Journal of Medical Research},
  year = {2023},
  doi = {10.4103/ijmr.ijmr_4148_20}
}
Kostenlos starten →